Does prostate removal cause impotence? Often it does, but not inevitably. Radical prostatectomy removes the prostate and seminal vesicles, and the erectile nerves run millimeters from the prostate capsule. Whether those nerves survive surgery, and whether the penis's blood supply and tissue stay healthy afterward, determines erections. Modern nerve-sparing techniques preserve potency in a substantial share of men, especially those who were potent before surgery.
The mechanism: why surgery, not hormones, drives the risk
Erections are a vascular event triggered by nerves. The cavernous nerves branch from the pelvic plexus, run posterolateral to the prostate at roughly the 5 and 7 o'clock positions, and reach the corpora cavernosa. They do not run through the prostate. They run against it, often within 1 to 2 millimeters of the capsule. A surgeon's plane of dissection along the prostate therefore decides whether these fibers are stretched, cauterized, or cut.
Two injuries stack on top of each other. The first is direct: nerve fibers are bruised by traction or heat, or severed when cancer sits against the capsule and the surgeon must take a wider margin. The second is indirect and slower. Cutting the nerves triggers apoptosis in the cell bodies that supply them, a Wallerian-type degeneration that continues for weeks after the operation. That is why potency sometimes declines months after surgery rather than immediately.
The penis also loses more than nerve input. Part of its venous drainage runs through the prostate and pelvic plexus. Removing the prostate can leave the penis with reduced oxygen delivery during nocturnal erections, and the smooth muscle inside the corpora cavernosa begins to fibrose when it is not regularly oxygenated. This is the counterintuitive part: the biggest long-term threat to potency after prostatectomy is not the severed nerve. It is the disuse of erectile tissue during the months when nerve function is recovering.
The testosterone question is a persistent misconception. The prostate does not produce testosterone; the testes do through Leydig cells. Prostatectomy does not lower testosterone and does not cause impotence by hormonal means. Any hormonal cause must be sought elsewhere.
Quantified context: how often, and how much it depends on the man
Published potency rates after radical prostatectomy range from roughly 20 to 80 percent, and the spread is not study noise. It reflects nerve-sparing status, baseline function, age, and how potency is defined. A man who needs a PDE5 inhibitor to achieve penetration is potent by some definitions and impotent by others; trials that count only unassisted intercourse report lower numbers than trials that count "adequate for intercourse with or without medication."
Three variables dominate the prediction:
Baseline erectile function. Men with a preoperative erectile function score in the normal range have the highest recovery rates; men with moderate or severe dysfunction before surgery have far less to recover. Nerve-sparing status. Bilateral nerve preservation, possible when cancer is confined and not abutting the capsule, yields the best outcomes. Unilateral preservation roughly halves the achievable rate. Non-nerve-sparing surgery makes spontaneous erection unlikely. Age and comorbidity. Diabetes, hypertension, smoking, and prior radiation each reduce the odds of functional recovery, because they have already damaged the microvasculature the nerves must signal into.
A 900-word explainer will tell you the range is "20 to 80 percent." That number is real but nearly useless alone. The actionable version is this: a potent man under 65 with bilateral nerve sparing and no diabetes has a genuinely favorable prognosis; a man over 70 with preexisting moderate dysfunction does not, and should plan for penile rehabilitation as a default rather than a contingency.
Timeline: recovery is measured in months, not days
Nerve recovery after prostatectomy follows a predictable arc, with wide individual variation. The absence of erections at three months is not failure, and the presence of morning erections at six months is not a guarantee of stability. The timeline below reflects typical patterns; none of it is a promise for any individual.
| Time after surgery | Typical erectile state | What matters clinically |
|---|---|---|
| 0 to 6 weeks | No spontaneous erections expected | Catheter care, wound healing, pelvic floor rest |
| 6 weeks to 3 months | Some men report early partial tumescence | Starting rehabilitation varies by surgeon; discuss timing |
| 3 to 6 months | First meaningful partial erections in nerve-spared men | Continue oxygenation strategy; reassess |
| 6 to 12 months | Most recovery of spontaneous function occurs here | If none, escalate to vacuum device or injections discussion |
| 12 to 18 months | Continued slow improvement is possible | Late recovery is documented but less common |
| 18 to 24 months | Plateau in most men | Definitive assessment of residual function |
The practical implication: decisions about whether surgery "caused" impotence should not be made at three months. Surgery set the conditions; the rehabilitation window that follows determines how much tissue survives to use them.
Edge cases: when the anatomy forces the surgeon's hand
Nerve sparing is a cancer-control decision before it is a potency decision. When cancer abuts or invades the capsule, or when the surgeon cannot achieve a negative margin without taking the neurovascular bundle, a positive surgical margin means the cancer may recur. Potency takes second place. Men should understand this trade-off before consenting, not after.
Other edge cases change the calculus:
Salvage surgery after radiation. Prior radiation damages the nerves and vasculature, and potency recovery after salvage prostatectomy is markedly lower than after primary surgery. Very large prostates and pelvic anatomy. A large gland compresses the bundles and makes the dissection plane less forgiving. Unilateral versus bilateral disease. Unilateral nerve sparing is often the realistic option when cancer sits on one side; the preserved side can sometimes carry erectile function, but the rate is lower than bilateral. Pelvic radiation or androgen deprivation given before surgery. Both impair the tissue the nerves must drive.
Here is the professional caveat that most consumer articles skip: "nerve sparing" describes an intention, not a guarantee. A surgeon may attempt bilateral preservation and still sacrifice fibers because of intraoperative findings, and the operative note should be read by the patient and discussed at follow-up.
Misconceptions worth correcting
The most common error is assuming that prostate removal means the penis is "disconnected." It is not. The penis remains innervated by branches that may be preserved, and the vascular supply, while altered, remains. The second error is assuming that a return of sensation equals a return of rigidity; they are different functions, and sensation often recovers before erectile capacity.
A third misconception is that testosterone therapy will fix post-surgical impotence. It will not restore severed nerves, and it is not a standard treatment for this problem. A fourth is that potency outcomes are identical across surgical approaches. They are not; the evidence favors high-volume surgeons and nerve-sparing technique, and the difference between an experienced and an occasional operator is one of the largest variables in the literature.
If your surgeon quotes a single number without asking about your baseline function, age, and nerve-sparing plan, that number is not about you.
Practical actions: what to do before and after surgery
A concrete rehabilitation plan matters more than any single statistic. The following steps are general and should be individualized with your surgeon and a urologist or sexual medicine specialist.
Get a baseline erectile function assessment before surgery, ideally with a validated questionnaire and a conversation about morning erections. Ask explicitly whether bilateral nerve sparing is planned, and if not, why. Ask what the surgeon expects for your potency. Discuss penile rehabilitation timing at the preoperative visit, not after discharge. The goal is regular oxygenation of erectile tissue during the recovery window. Stop smoking and optimize blood pressure and glucose before surgery; these change the microvasculature the nerves depend on. After surgery, report any absence of erections at three months and ask whether a vacuum erection device or other rehabilitation is appropriate for you.
Red flags that should prompt a call rather than a wait:
No erection at all by 12 months after bilateral nerve sparing New penile curvature or a palpable plaque suggesting Peyronie's disease Persistent pain, swelling, or shortening of the penis Urinary retention or worsening incontinence alongside erectile change New depressive symptoms; sexual function and mood are linked, and both deserve assessment
Limitations: what the evidence cannot tell you
The honest limit is that potency after prostatectomy is a probability, not a prediction. Published rates come from series with different definitions, different surgeon volumes, and different follow-up lengths, and none of them describe you. The most defensible statement a clinician can make is conditional: given your age, baseline function, comorbidity, and the nerve-sparing plan, your odds fall somewhere in a range, and rehabilitation can improve the outcome within that range.
Two further limits deserve mention. First, most potency data come from men treated at academic or high-volume centers; community outcomes may differ. Second, long-term data beyond five years are thinner than short-term data, and late decline from aging and vascular disease can be mistaken for surgical failure. The mechanism is stable and well understood; the individual number is not. That is the difference between a real explainer and a thin one.